发明名称 NOVEL URACIL DERIVATIVES AND MEDICINAL USE THEREOF
摘要 <p>It is intended to provide an uracil derivative represented by the following general formula (I): (I) wherein X represents a group selected from among NHCO, NHCH2, CO, CONH and CH2NH; R&lt;1&gt; represents hydrogen or optionally substituted C1-6 alkyl; R&lt;2&gt; represents a group of the following general formula (II) or (III): (II) (III) (wherein m is 0 or 1; n is an integer of from 1 to 3; Y represents OH or NH2; and a dotted line shows a binding position), provided that when R&lt;2&gt; is a group of the general formula (III), X represents NHCO or NHCH2; R&lt;3&gt; and R&lt;4&gt; independently represent each hydrogen or C1-6 alkyl; and Ar represents phenyl substituted by C1-6 alkyl at the o- and m-positions, optionally substituted heteroaryl or a bicyclic aromatic group; its pharmaceutically acceptable salt, and a remedy containing the above uracil derivative or its pharmaceutically acceptable salt as the active ingredient for, in particular, allergic diseases relating to a type IV allergic reaction, i.e., a novel compound useful in treating diseases in which a type IV allergic reaction participates and a remedy for allergic diseases containing the same as the active ingredient.</p>
申请公布号 WO2004026842(A1) 申请公布日期 2004.04.01
申请号 WO2003JP11859 申请日期 2003.09.17
申请人 SUMITOMO PHARMACEUTICALS CO., LTD.;ISOBE, YOSHIAKI;TOBE, MASANORI;INOUE, YOSHIFUMI;ISOBE, MASAKAZU 发明人 ISOBE, YOSHIAKI;TOBE, MASANORI;ISOBE, MASAKAZU
分类号 A61K31/513;A61P17/04;A61P37/08;C07D239/54;C07D239/545;C07D405/06;C07D405/12;C07D405/14;(IPC1-7):C07D239/54 主分类号 A61K31/513
代理机构 代理人
主权项
地址